Growth and apoptosis responses in glioblastoma cells
Cell-based study · Human U38 and U87 glioblastoma cell lines [1]
Ki8751 reduced the increase in CCK-8 signal over time and increased Annexin V/PI-defined apoptosis relative to vehicle. These are cell-culture results; the two active concentrations do not establish a monotonic concentration–response relationship.
| Endpoint | Reported result | Reference |
|---|---|---|
| CCK-8 signal normalized to optical density at time 0 | Relative proliferation signal Lower signal increase than vehicle at 2.5 and 5 µM across the reported time course; mean ± SEM, n = 3. No exact fold inhibition extracted. | [1] |
| Annexin V/PI-defined apoptotic-cell percentage | Apoptosis Increased relative to vehicle; mean ± SEM, n = 3. No exact percentages extracted from plotted bars. | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 2.5 and 5 µM
- Exposure duration
- 24, 48 and 72 h
- Method
- Drug exposure in cell culture; CCK-8 and Annexin V-FITC/PI assays
- Vehicle
- 0.01% DMSO
- Reported limits
- Figure captions report n = 3 and mean ± SEM, without specifying the biological replicate unit for these assays. Salt/hydration, lot and purity are not specified.
Methods and source locations
Compound reported in the paper: Ki8751; Compound label in the paper: Ki8751
Compound-level research evidence; no inference about the performance of an Adooq lot.
Figure 1D–G and caption; Results Sec18; Methods Sec4 and Sec6
CCK-8 signal normalized to optical density at time 0: CCK-8; signal is a metabolic readout rather than direct cell counting. — Figure 1D and caption; Methods Sec6; Results Sec18
Annexin V/PI-defined apoptotic-cell percentage: Annexin V-FITC/PI staining with flow cytometry. — Figure 1E and caption; Methods Sec6; Results Sec18